Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Journey Colab
Biotech
Roche taps new CEO—Chutes & Ladders
Roche has officially confirmed that Thomas Schinecker, Ph.D., will replace Severin Schwan as CEO, effective March 15, 2023.
Gabrielle Masson
,
Max Bayer
Jul 22, 2022 9:30am
Journey Colab scores $12M to move psychedelic into the clinic
Sep 7, 2021 7:00am
Psychedelics inch toward approval, but market may not be ready
Aug 17, 2021 10:40am
Journey debuts with $3M, new development model for psychedelics
Oct 26, 2020 3:14pm